Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are skin tumors with different invasive potential. In this work, we analysed mRNA differential expression between seven BCC and five SCC and their normal skin counterparts using 1176 cDNA macroarrays and verification by RT-PCR to identify genes modulated in each tumor type. We identified 37 genes commonly modulated in both tumors and four genes specifically modulated in SCC. Among these latter RhoC and EMMPRIN genes seem to be of particular interest and could participate in SCC aggressivity. Oncogene (2003 Oncogene ( ) 22, 3500-3505. doi:10.1038 Keywords: DNA macroarray; basal cell carcinoma; squamous cell carcinoma Nonmelanoma skin cancer (NMSC), which includes basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is the commonest human malignancy. These two types of carcinoma differ substantially as to their progression behavior and origin. BCC appears de novo, grows slowly, essentially exhibits a local more or less infiltrative potential and hardly ever metastasizes, whereas SCC develops from precancerous lesions, is more locally aggressive and can threaten patients' lives through lymph node progression and visceral metastasis. Cytogenetic studies have defined strong genetic differences between BCC and SCC. In BCC, only limited chromosomal abnormalities are found mainly involving chromosome 9q and to a lesser extent chromosome 1. Conversely, allelic losses are multiple in SCC and include chromosomes 3p, 5q, 8p, 9p and q, chromosomes 13q, 17p and 17q (Quinn et al., 1994) .
Linkage and candidate gene studies in patients affected with the basal cell naevus syndrome, an autosomic dominant genodermatosis predisposing to the development of BCC, led to the mapping and subsequent cloning of the patched 1 tumor suppressor gene on chromosome 9q (Bale and Yu, 2001 ). The identification of this gene has highlighted the role of the hedgehog signaling pathway in BCC formation (Bale and Yu, 2001 ) and allowed, for the first time, the development of animal models for studying BCC formation in mice (Nilsson et al., 2000) . UV-induced mutations of the p53 tumor suppressor gene are the most frequent genetic alterations found in NMSC (Harris, 1996) , but are not preferentially associated with one subtype of NMSC and appear as an early event (Ren et al., 1996) . The emerging technology of cDNA macroarrays allows comparative analyses of mRNA expression of thousands of genes in parallel and permits molecular classification of tumors for diagnosis and prognosis purposes (Golub et al., 1999) . Additionally, gene expression profiling could facilitate the identification of key molecular markers for the comprehension of pathophysiological mechanisms of tumor formation. This could then lead to the development of new therapeutic strategies. To our knowledge, such analysis of human NMSC has not yet been reported in the literature although it should permit to clarify the molecular basis of skin tumor development.
In this study, we obtained the gene expression profile of 12 NMSC (five SCC and seven BCC) from 10 patients undergoing surgical resection of a histologically proven epidermal skin tumor at Saint-Louis hospital from October 2000 to October 2001 with their informed consent. For differential gene expression, RNA from both tumoral (five SCC and seven BCC) and normal epidermis from the same patient were collected and analysed using Atlas Human Cancer cDNA expression array (1176 genes, Clontech).
Results showed a large gene modulation in skin carcinomas compared to normal epidermis (Figure 1 ). Gene expression in SCC was more affected than that in BCC: in all SCC and BCC, respectively, 45 and 31% of all screened genes were at least twofold up-or down-regulated (two-tailed Mann-Whitney test, P ¼ 0.02). The differences observed between SCC and BCC regarding gene expression modulation are in agreement with what is observed at the DNA level, as it is not surprising that the numerous cytogenetic abnormalities found in SCC are associated with modulation of the expression of numerous genes, whereas the few chromosomal alterations found in BCC are associated with a lesser extent of gene expression modulation. However, we found no correlation between chromosomal localization of modulated genes and chromosomal aberrations found in NMSC.
First, we wanted to pick genes modulated in both types of skin carcinoma. In order to eliminate background noise in the analysis of the hybridization experiment, we applied stringent filters. We selected genes that showed more than twofold induction or repression (over their controls) in at least 4/5 SCC and/ or in at least 5/7 BCC. Moreover, the geometric mean ratio of these genes had to be statistically different from 1.0 (Student's t-test, Po0.05). In all, 179 upregulated genes passed these filters in SCC, whereas 51 passed them in BCC; 31 out of these 51 genes were found to be common with SCC ( Figure 1a ). Eight genes were found downregulated in SCC, 21 in BCC and six genes were downregulated in both tumor types (Figure 1) . Clearly, these data show that SCC are associated with upregulation of gene expression, whereas BCC are more Figure 1 Atlas Human Cancer cDNA (Clontech no. 7851-1) expression array analysis and representative hybridizations. Following surgery, tissue samples were immediately frozen in liquid nitrogen and kept at -801C until RNA extraction. Briefly, tumors were ground to powder under liquid nitrogen. Normal epidermis and frozen tissue sections were disrupted using a glass potter. Total RNA was obtained using Rneasy mini-kit (Qiagen) according to the manufacturer's instructions including Dnase I treatment to avoid genomic contamination. The macroarray analysis was performed as described in the manufacturer's user manual. Briefly, 5 mg of total RNA were converted to 33 P-labeled cDNA using [a- 33 P]dATP (Amersham), Powerscript reverse transcriptase and Atlas Human Cancer cDNA synthesis-specific primer (Clontech). Equal amounts of radiolabeled cDNA probes from normal epidermis and from tumor of the same patient were used for hybridization in parallel with two Atlas arrays from the same batch overnight at 681C. After stringent washes, the array membranes were exposed to a Kodak Phosphorimage screen for 5 days. Hybridization signals were acquired with a Storm 840 phosphorimager. The Software program Imagene version 4.1 (Biodiscovery) was used to quantify and normalize the data. For each patient, membrane hybridized with the tumor was compared with membrane hybridized with the normal epidermis. Spots with low signals (difference p1.0 between the signal spot and the background) in both membranes were not considered for further analysis. Local background signal was subtracted from the intensity of each spot. For each tumor, the level of modulation was determined as the ratio of the intensity of each spot of the membrane hybridized with tumoral sample divided by the signal of each spot of the membrane hybridized with the normal. Ratios were normalized with all spots having ratios lower than two standard deviations of all spot ratios (iterative algorithm). (a) Diagram of the number of genes found regulated in NMSC after cDNA macroarray analysis. Genes with at least twofold up-or downregulation in at least 4/5 SCC or in at least 5/7 BCC and with a geometric mean ratio statistically different from 1 (Student's t-test, Po0.05) were considered up-or downregulated. Portions of overlapping circles represent genes modulated both in BCC and in SCC. (b) Atlas Human Cancer cDNA expression array hybridization with 33 P-labeled cDNA probes derived from normal epidermis SCC (tumor 5), and BCC (tumor 6) of the same patient. Using Imagene Software, the filter hybridized with SCC or BCC and the filter hybridized with normal epidermis were overlayed (left or right panel, respectively). Filter hybridized with tumoral sample is colored in green, filter hybridized with normal epidermis is colored in red. Genes that are upregulated, downregulated or not modulated then appeared green-, red-or yellow-colored, respectively. Note the clear numerous upregulations observed in BCC and mostly in SCC compared to normal epidermis. The 37 genes found modulated both in BCC and in SCC are circled. The four genes specifically upregulated in all SCC studied are boxed: CPR2 (1), PKCI-1 (2), RhoC (3), EMMPRIN (4) associated with downregulation of gene expression. However, a small number of genes (n ¼ 37) are up (n ¼ 31) or down (n ¼ 6) regulated in both tumor types. The list of the 37 genes found modulated in both NMSC types is detailed in Table 1 . To test the reliability of macroarray hybridization results, we randomly analysed the expression of eight of these genes commonly expressed in NMSC by semiquantitative reverse transcription-PCR (RT-PCR). In each case, the results of RT-PCR confirmed the differential gene expression identified by macroarray hybridization (Figure 2a) .
These 37 genes could correspond to key genes modulated during skin tumor formation. They belong to various families. Epidermal differentiation marker expression such as cytokeratin 1 and 10 were found downmodulated as described in NMSC tumors (Perkins et al., 1992) , which underlines the reliability of our screening procedure. We found a decreased expression of other keratinocyte differentiation markers such as desmocollin 1 and 3. The most upregulated genes belonged to the immune system. Obviously, this represents contamination with nonkeratinocyte cells, which can be explained by the fact that the tissue samples were not microdissected. The presence of an inflammatory infiltrate was 'moderate' in all samples studied and could be the source of this expression. Additionally, intravascular lymphocyte contamination could also be a source for immunoglobulin gene expression. Genes encoding for the extracellular matrix can be expressed by keratinocytes and fibroblasts and both could participate in tumor stromal reaction. A number of them (i.e. fibronectin, biglycan, stromelysin 3, tenascin) have already been reported as overexpressed during carcinogenesis and/or metastasis including skin carcinogenesis (Asch et al., 1999; Thomas et al., 2001) , which again comforts our gene selection procedure. Genes involved in cell adhesion are known to be modulated in different tumors. Cadherin 3, also called P-cadherin, is a calcium-dependent cell-to-cell adhesion molecule involved in the selective adhesion of epidermal cells. P-cadherin is crucial for the maintenance of normal epidermal architecture. During human skin development, P-cadherin expression is closely related to segregation of basal layers as well as to the arrangement of epidermal cells into eccrine ducts. Aberrant P-cadherin expression is observed in various cancers (melanoma, prostatic cancer) (Matsuyoshi et al., 1997; Paul et al., 1997) and could play a role in tumor progression. The transcription factor c-jun was found upregulated and recent studies have emphasized its role in murine skin tumorigenesis, but increased expression was not previously reported in human NMSC (Zoumpourlis et al., 2000) . The hypoxia-inducible factor 1 alpha was also upregulated. It encodes for another transcription factor involved in critical pathways of tumor growth and metastasis that associates with more aggressive tumors (Bos et al., 2001) .
We then wanted to identify genes specifically modulated in one type of NMSC. For this, we selected genes that were modulated in one type of NMSC with the precedently defined criteria and that were not modulated at all in the other type of NMSC (all ratios had to be comprised between 0.56 and 1.8). Under these conditions, we found no specific gene modulation in BCC. GLI-1, which is a nuclear target of the hedgehog signaling pathway, has been shown to be overexpressed in BCC (Dahmane et al., 1997; Nilsson et al., 2000) illustrating the primary role of GLI-1 in BCC development. Unfortunately, no sequence of this gene was spotted on the array we used. We compared the expression of GLI-1 by RT-PCR in all our tumor samples with normal skin (Figure 2b ) and found a high expression of GLI 1 in all BCC analysed, whereas in SCC no or low GLI 1 expression level was detected. Expression of GLI 1 in some SCC has already been reported (Ping et al., 2001) . Other members of the hedgehog signaling pathway, Smo and ptc, are preferentially overexpressed in BCC (Kallassy et al., 1997) . In our study, PTC was not detected in most of our tumors, but Atlas array technology is less sensitive than RT-PCR. The level of modulation of smo was above 2.0 in 4/7 BCC and varied among individual SCC (e.g. 3.3-fold repressed in tumor 1 and 2.3-fold induced in tumor 3) (data not shown). Altogether these results show that, for the moment, only GLI1 overexpression is specific for BCC.
SCC mRNA analysis showed specific upregulation of four genes: RhoC, extracellular matrix metalloproteinase inducer (EMMPRIN), cell cycle progression 2 protein and PKC-interacting protein 1 (PKCI-1) ( Table 2) .
RhoC belongs to the Rho family (Rho, rac, cdc42), which is part of the Ras superfamily of small GTPases. Activation of Rho proteins by extracellular factors leads to assembly of actin-myosin contractile filaments and focal adhesion complexes. Rho controls actin stress fiber and focal adhesion contact formation. Recently, several studies have shown links between RhoC and invasive phenotype in different tumor types. In human mammary epithelial cells, RhoC is a transforming oncogene and can lead to a highly invasive phenotype, akin to that seen in inflammatory breast cancer (van Golen et al., 2000) . Additionally, RhoC is overexpressed in highly metastatic melanoma cells (Clark et al., 2000) . So RhoC seems to play an essential role in invasive phenotype and could play an important role in SCC invasiveness.
EMMPRIN is a transmembrane glycoprotein, a member of the immunoglobulin superfamily, and is also strongly thought to play a role in the invasion and metastasis of cancer cells. It is enriched on the surface of most tumor cells and stimulates adjacent stromal cells to produce elevated levels of several matrix metalloproteinases (MMPs) (Biswas et al., 1995) . These MMPs become concentrated around tumor cells, thus enhancing the ability of the latter to invade extracellular matrices. Recently, Bordador et al. (2000) showed that EMMPRIN is highly expressed in oral SCC, facilitates tumor cell motility and mediates tenascin matrix deposition (see Table 1 ). This tenascin protein has been reported to possess antiadhesive or motility-promoting properties, suggesting a role in tumor cell motility. We Cytoskeleton/cell adhesion The ratio of gene expression was determined by the expression level in tumor sample divided by the expression level in normal sample of the same patient. Genes with at least two fold up-or downregulation in at least 4/5 SCC and in at least 5/7 BCC and with a geometric mean ratio statistically different from 1 (Student's t-test, Po0.05) were considered modulated. When expression in both tumoral and normal sample was below baseline, the ratio of gene expression was marked as absent (A). When expression in tumoral sample was below baseline, the ratio of gene expression was marked as repressed (rep). When expression in normal sample was below baseline, the ratio of gene expression was marked as induced (ind). s: upregulation; r: downregulation also found a number of other metalloproteinases overexpressed in our NMSC, but not specifically in SCC. Specific overexpression of RhoC and EMMPRIN in SCC was further validated in independent skin carcinomas (data not shown) by semiquantitative RT-PCR.
The cell cycle progression 2 protein belongs to a family of genes involved with the basic cell machinery and restoring cell cycle progression. So far its implication in cancer development has not been reported.
PKCI-1 is a member of the HIT family of proteins including the tumor suppressor FHIT. To date, the biological activity of PKCI-1 has not yet been identified and no implication in tumoral development has been described. Several results raise the possibility that Figure 2 RT-PCR analysis of differential gene expression. The reverse transcription followed by specific PCR was realized with Clontech kits (RT for PCR and Titanium Taq PCR kit) according to the manufacturer's instructions. Briefly, 1 mg of total RNA was subjected to reverse transcription using random hexamers (20 pmol) and 200 U MMLV reverse transcriptase. PCR was carried out with 1/20 of previously synthesized cDNA and specific primers (Clontech source). For the different genes, the number of cycles was optimized to avoid the plateau phase and specific cDNAs were amplified at 681C. PCR products were subjected to migration onto 2% agarose gel and specific ethidium bromide fluorescent signals were quantified with Biorad Imager Gel Doc. Each signal was normalized with an appropriate housekeeping gene (HK gene) (ubiquitin C or 60S L 13 A ribosomal protein). For each tumor type (BCC or SCC), the PCR was carried out from the cDNA that induced the strongest signal on membranes. The HK genes were ubiquitin C and ribosomal protein L13A for basal and squamous cell carcinomas, respectively. (a) Genes found modulated in both BCC and SCC. Eight genes among 37 were arbitrarily selected for RT-PCR confirmation. (b) Gli-1 expression. (c) Genes found modulated solely in SCC PKCI-1 may bridge the interactions between basal transcription factors and transcription activators (Klein et al., 1998) . In conclusion, mapping the genetic identity of our NMSC samples has revealed clear differences in gene modulations between SCC and BCC. These differences have allowed us to pinpoint the potential role of four previously unreported genes in skin carcinogenesis, which could be of relevance in explaining SCC development. Additional studies are on the way to confirm and detail how these genes could participate in the invasive and metastatic potential of SCC tumors. To select specifically modulated genes in a type of NMSC (SCC or BCC), genes had to be modulated as described for Table 1 in one type of NMSC and, in addition, ratios had to stay between 0.56 and 1.8 in the other type of tumor in all patients. a Values for two-tailed Mann-Whitney test comparing distribution of ratios in BCC and in SCC. All tests and comparisons were performed at a 5% two-sided significance level
